CGC Meeting

The 9th Annual CGC Meeting will be held in Nashville, TN on August 6th through 8th, 2018. Click here for more information >>
The CGC annual meeting is a unique forum for education and discussion of best practices in laboratory genomics. The CGC is committed to advancing clinical diagnostics through the use of genomic technologies (microarray, massively parallel sequencing, etc.) and improving the accompanying data processing. Our meetings bring together laboratorians, clinicians and researchers with a shared interest in early adoption, performance and interpretation of leading edge technology for cancer and constitutional genomics. Valuable practical aspects of the meetings derive from workshops, expert-panels and round-table discussions on topics relevant for clinical practice, including data interpretation, access to shared resources and best practices in reporting and follow-up. Attendees are encouraged to take an active role in CGC initiatives by joining committees and working groups engaged in developing guidelines and resources for clinical testing. Come learn from colleagues and offer your experience to others in an informal, engaging setting while enjoying the dynamic city of Nashville in August.
For additional information and registration click here >> .


• Clinical Applications of Array, NGS, and Whole-genomic sequencing (WGS) in Cancer Testing, along with conventional cytogenetics and FISH
• Immune Checkpoint inhibitors (PD-1/PD-L1) and Predictive Tests
• Epigenetics
• Challenges to Delivering on the Promise of Personalized Medicine in Cancer Care
• Validation and Quality Control of Arrays, NGS, and Cell-free DNA Analysis
• Clinical Interpretation of Sequence and Copy Number Variants
• European vs North America Experiences in Clinical Genomic Testing
• Bioinformatics, Clinical Pipelines, Databases and Datasharing for Publication
• Challenging/Teaching Cases
• Billing, Reimbursement, Laboratory Advocacy
… with extensive networking opportunities.


Dr. Clara D BloomfieldCLARA D. BLOOMFIELD, MD.
Clara D. Bloomfield, MD is a distinguished university professor at The Ohio State University (OSU) and is the William Greenville Pace III Endowed Chair in Cancer Research. She is the inaugural OSU Cancer Scholar and Senior Advisor to the OSU Comprehensive Cancer Center and The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Click here to continue reading >>

Dr. Bloomfield earned her MD from the University of Chicago and completed training in internal medicine and medical oncology at the University of Minnesota, where she became a full professor in just 7 years. Prior significant academic administrative positions include serving as the Chair of the Department of Medicine at Roswell Park Cancer Institute, the Chief of the Division of Oncology at the State University of New York at Buffalo (1989-1997), the Director of the Division of Hematology and Oncology at OSU (1997-2001), and the Director of the OSU Comprehensive Cancer Center (1997-2003).

Dr. Stefan PfisterDR. STEFAN PFISTER, M.D.
In 2012, Stefan Pfister, MD, was appointed acting head of the Division of Pediatric Neurooncology at the German Cancer Research Center (DKFZ). Since 2014, he has served as a professor for pediatric neurooncology at the DKFZ as well as permanent chair of the department. In 2016, he was appointed Director of the Preclinical Program of the new Therapy and Research Center for Pediaric Oncology and Hematology.
Click here to continue reading >>

Being a pediatrician by training, Dr. Pfister received his MD from Tübingen University, and his clinical education at Mannheim and Heidelberg University Hospitals. As a physician-scientist, he completed postdoctoral fellowships with Christopher Rudd at the Dana-Farber Cancer Institute/Harvard Medical School, and with Peter Lichter at the German Cancer Research Center, Division of Molecular Genetics. Dr. Pfister´s research focuses on the genetic and epigenetic characterization of childhood brain tumors by applying next-generation profiling methods, the development of faithful models, and the preclinical testing of new treatment options using these models.

In all his activities, translating novel findings into a clinical context is of highest priority. For his translational neurooncology projects, Dr. Pfister received the German Cancer Award in 2012.

Dr. Ross LevineDR. ROSS LEVINE, M.D.
Ross Levine, MD, is a physician-scientist; member of the Human Oncology and Pathogenics Program; an attending physician on the Leukemia Service, Department of Medicine; the Laurence Joseph Dineen Chair in Leukemia Research; and, the director of the Memorial Sloan Kettering Center for Hematologic Malignancies.
Click here to continue reading >>

Dr. Levine received his AB from Harvard College and MD from Johns Hopkins. Dr. Levine served as a resident in Internal Medicine at the MGH and subsequently as a Hematology-Oncology Fellow at DFCI. He then joined Gary Gilliland’s laboratory as a postdoctoral fellow and performed kinome sequencing at the Broad Institute to identify JAK2V617F and MPL mutations in MPN patients. In September 2007 he was recruited to MSK and the Human Oncology and Pathogenesis Program while he sees patients on the Leukmia Service.

The focus of Dr. Levine’s work is to improve our understanding of the genetic basis of myeloid malignancies, with a specific focus on the role of oncogenic disease alleles in the pathogenesis of myeloproliferative neoplasms (MPN) acute myeloid leukemia (AML).

Dr. Levine’s current efforts are focused on the following areas:

• Role of mutations in epigenetic modifiers in MPN and AML pathogenesis and therapeutic response
• Investigation of the role of different signaling pathways in hematopoietic transformation
• Characterization of targeted therapies in MPN/AML patients using in vitro and in vivo assays, and elucidation of the mechanisms of resistance to these therapies


Are you a trainee or technologist? Travel awards available for exceptional abstracts!


The CGC Annual Meeting offers numerous opportunities for industry and academic partners to market and advertise their products and services. Through a series of scheduled networking sessions sponsors can connect with participants from major diagnostic laboratories across North America. For more information regarding sponsorship and advertising opportunities, click here. Sponsorship commitment forms can be found here.

Comments are closed.